معرفی
Dr. Carolyn S.P. Lam is a tenured Full Professor at Duke-National University of Singapore Medical School and Senior Consultant Cardiologist at National Heart Centre Singapore. She pioneered Singapore’s first Women’s Heart Clinic and co-founded Us2.ai, an AI-driven cardiovascular diagnostics startup.
- Academic Affiliation: Duke-National University of Singapore (Tenured Full Professor)
- Clinical Role: Senior Consultant Cardiologist at National Heart Centre Singapore
- Startup Leadership: Co-founder of Us2.ai, focusing on AI automation in echocardiography
Her research focuses on heart failure with preserved ejection fraction (HFpEF), sex differences in cardiovascular disease, and clinical trial design. Key contributions include the PARAGON and EMPEROR-Preserved trials, leading to the first FDA-approved HFpEF treatment. She has published over 350 articles in top journals like NEJM, JAMA, and Lancet.
Recent publications highlight her work on SGLT2 inhibitors, GLP-1 agonists, and mineralocorticoid receptor antagonists in heart failure. Thematic trends include pharmacological intervention, AI in diagnostics, and sex-specific medicine.
- Scientific Awards
- NMRC Senior Investigator Clinician Scientist Award
- Clarivate Highly Cited Researcher (2021, Clinical Medicine)
- Expertscape World Expert in Heart Failure
- 2021 ESC Guidelines Task Force Appointment
- International Honorary Fellow, Heart Failure Society of America (2021)
As a mentor, she leads the ASIAN-HF multinational study across 11 Asian countries and served on global clinical trial executive committees. Her Us2.ai startup won the FedEx Small Business Grant Contest (2021) and Forbes Asia 100 to Watch (2020). She also contributes to public health education via the TV show Body and Soul and hosts the podcast Circulation On The Run.
